Impurity Thresholds
Impurity Thresholds is a regulatory and scientific criterion that defines the maximum acceptable level of process-related impurities in a pharmaceutical product based on their potential impact on safety, quality, and efficacy.
37
Publications
1.4K
Citations
179
Authors
71
Institutions
Publications per year
2017–2026
8
Parents
37
Impurities in Oligonucleotide Drug Substances and Drug Products
Daniel C. Capaldi, Andy Teasdale, Scott P. Henry et al. · Nucleic Acid Therapeutics · 2017 · 130 citations
Prediction of threshold value for FGA formation
Aiguo Zhao, Jijia Xie, Chengqi Sun et al. · Materials Science and Engineering A · 2011 · 92 citations
1–5 of 37
179
3
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 179
71

Culham Centre for Fusion Energy
Abingdon, United Kingdom
3 h-index
16 publications
524 citations
Culham Science Centre
Abingdon, United Kingdom
3 h-index
16 publications
524 citations
Forschungszentrum Jülich
Jülich, Germany
2 h-index
18 publications
418 citations
United States Pharmacopeial Convention
Rockville, United States
2 h-index
4 publications
100 citations
Max Planck Institute for Plasma Physics
Garching, Germany
2 h-index
17 publications
359 citations

Chinese Academy of Sciences
Beijing, China
2 h-index
6 publications
472 citations
Princeton University
Princeton, United States
2 h-index
16 publications
517 citations
Max Planck Society
Munich, Germany
2 h-index
17 publications
359 citations
1–8 of 71
4 publications · 74 citations
4
h-index
2 publications · 62 citations
2
h-index
1 publications · 22 citations
1
h-index
1 publications · 13 citations
1
h-index
1 publications · 15 citations
1
h-index
1–5